Lab
Prymed Medical Care, INC
Prymed Medical Care, INC was paid $913K by Medicaid between Jan 2018 and Oct 2024, across 65 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 15% of everything it billed.
33Billing provider infoPRYMED MEDICAL CARE, INC
CIALES, PR 00638
CIALES, PR 00638
33aNPI1063520252assigned 08/28/2006
33bProvider typeClinical Medical Laboratory
28Total paid$913K
24GClaims96,557
24DCodes billed65
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#137 of 777
Median peer was paid$278K
This provider vs. median3.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,635 | $139K | |
| 2019 | 13,913 | $124K | |
| 2020 | 11,813 | $124K | |
| 2021 | 25,156 | $243K | |
| 2022 | 6,440 | $71K | |
| 2023 | 13,268 | $120K | |
| 2024incomplete | 10,332 | $92K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 15% | 8,532 | 8,222 | $134K |
| 80061 | Lipid panel | 12% | 9,051 | 8,753 | $113K |
| 80053 | Comprehensive metabolic panel | 12% | 10,849 | 10,455 | $107K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9.8% | 12,383 | 11,843 | $90K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5.7% | 2,168 | 1,896 | $52K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.0% | 742 | 679 | $37K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.6% | 3,693 | 3,571 | $33K |
| 86580 | 3.3% | 3,828 | 3,691 | $30K | |
| 84439 | 2.9% | 2,770 | 2,691 | $26K | |
| 36415 | Collection of venous blood by venipuncture | 2.7% | 10,639 | 9,956 | $25K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.2% | 813 | 782 | $20K |
| 82274 | 2.0% | 1,437 | 1,378 | $19K |
53 more codes
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.9% | 670 | $18K |
| 81000 | 1.9% | 5,781 | $17K | |
| 84153 | 1.7% | 891 | $15K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.5% | 631 | $14K |
| 86592 | 1.3% | 3,077 | $12K | |
| 81001 | 1.3% | 3,554 | $12K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.3% | 243 | $12K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.0% | 1,235 | $9K |
| 87590 | <1% | 426 | $8K | |
| 87177 | <1% | 974 | $8K | |
| 87088 | <1% | 991 | $7K | |
| 83655 | <1% | 545 | $7K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 225 | $6K |
| 82043 | <1% | 1,056 | $6K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 326 | $6K |
| 87490 | <1% | 302 | $6K | |
| 87070 | <1% | 679 | $5K | |
| 87485 | <1% | 276 | $5K | |
| 85730 | <1% | 840 | $5K | |
| 82607 | <1% | 324 | $5K | |
| 87899 | <1% | 425 | $5K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 113 | $4K |
| 80074 | <1% | 79 | $4K | |
| 82947 | <1% | 947 | $3K | |
| 85610 | <1% | 838 | $3K | |
| 86701 | <1% | 296 | $3K | |
| 87536 | <1% | 35 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 168 | $3K |
| 84478 | <1% | 445 | $2K | |
| 82044 | <1% | 459 | $2K | |
| 86328 | <1% | 57 | $2K | |
| 82465 | <1% | 408 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 231 | $2K |
| 82270 | <1% | 461 | $1K | |
| 86738 | <1% | 81 | $1K | |
| 0002A | <1% | 27 | $1K | |
| 82950 | <1% | 213 | $936.61 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 26 | $810.20 |
| 86703 | <1% | 66 | $756.34 | |
| 85651 | <1% | 220 | $702.04 | |
| 87338 | <1% | 52 | $680.00 | |
| 86361 | <1% | 27 | $661.28 | |
| 84703 | <1% | 56 | $388.20 | |
| 84436 | <1% | 55 | $329.29 | |
| 86803 | <1% | 25 | $320.79 | |
| 82951 | <1% | 13 | $147.24 | |
| 82570 | <1% | 31 | $139.68 | |
| 87164 | <1% | 12 | $114.46 | |
| 80069 | <1% | 13 | $100.54 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 689 | $95.16 |
| 83540 | <1% | 12 | $75.82 | |
| 84550 | <1% | 12 | $53.58 | |
| 86140 | <1% | 14 | $34.68 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRIVERA, GLADYS (EXECUTIVE DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Prymed Medical Care, INC | Ciales, PR | $2.12M |
| Prymed Medical Care, INC | Vega Baja, PR | $771K |
| Rayosx Prymed Medical Care, INC. | Ciales, PR | $380K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.